Congenital Heart Defect Devices Market Outlook Indicates Strong Revenue And CAGR Growth Through 2030
How Much Growth Is Anticipated In The Congenital Heart Defect Devices Market Size From 2026 To 2035?
The congenital heart defect devices market size has grown strongly in recent years. It will grow from $3.11 billion in 2025 to $3.34 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising incidence of congenital heart defects, advancements in pediatric cardiac surgery, increasing survival rates of congenital heart patients, expansion of specialized cardiac care centers, growing awareness of early congenital defect diagnosis.
The congenital heart defect devices market size is expected to see strong growth in the next few years. It will grow to $4.45 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing focus on early diagnosis and intervention, rising demand for minimally invasive pediatric cardiac treatments, expanding access to advanced cardiac care in emerging markets, growing population of adults with congenital heart disease, continuous innovation in implantable cardiac devices. Major trends in the forecast period include rising adoption of minimally invasive congenital heart procedures, increasing use of transcatheter and implantable cardiac devices, growing focus on early-life and pediatric cardiac interventions, expansion of device-based therapies for complex heart defects, increasing demand for long-term cardiac monitoring and support devices.
Claim Your Free Report Sample Today:
What Significant Demand Drivers Are Anticipated To Influence The Congenital Heart Defect Devices Market Over The Coming Years?
The increasing number of minimally invasive procedures is expected to propel the growth of the congenital heart defect device market. Minimally invasive procedures involve performing surgical interventions with small incisions or through natural body openings, often using specialized tools and techniques to minimize trauma and enhance recovery. The increase in minimally invasive procedures is due to advancements in technology, patient preference for less invasive treatments, improved surgical techniques, and the benefits of reduced recovery times and complications. Congenital heart defect devices are used for minimally invasive procedures by facilitating the diagnosis, treatment, and management of heart abnormalities through techniques that involve smaller incisions or catheter-based approaches. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based organization, in 2023, plastic surgeries increased by 5%, while minimally invasive procedures rose by 7% compared to the previous year. Therefore, the increasing prevalence of minimally invasive procedures is driving the market for congenital heart defect devices market.
What Segment Divisions Provide The Most Valuable Insights Into The Congenital Heart Defect Devices Market?
The congenital heart defect devices market covered in this report is segmented –
1) By Device Type: Catheters, Pacemakers, Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Leadless Pacemakers, Implantable Cardioverter Defibrillators, Biventricular Devices, Implanted Cardiac Loop Recorders, Other Device Types
2) By Defect Type: Atrial Septal Defect, Ventricular Septal Defect, Atrioventricular Septal Defect, Tricuspid Atresia, Truncus Arteriosus, Other Defect Types
3) By End user: Hospitals, Specialty Clinics, Academic And Research Institute, Other End Users
Subsegments:
1) By Catheters: Balloon Catheters, Diagnostic Catheters, Guiding Catheters
2) By Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Leadless Pacemakers
3) By Implantable Cardioverter Defibrillators: Single-Chamber Icds, Dual-Chamber Icds, Subcutaneous Icds
4) By Biventricular Devices: Crt-P (Cardiac Resynchronization Therapy Pacemakers), Crt-D (Cardiac Resynchronization Therapy Defibrillators)
5) By Implanted Cardiac Loop Recorders: Traditional Implantable Loop Recorders, Subcutaneous Implantable Loop Recorders
6) By Other Device Types: Transcatheter Heart Valves, Ventricular Assist Devices (VADS)
Which Trends Are Reshaping Growth Within The Congenital Heart Defect Devices Market?
Major companies operating in the congenital heart defect devices market are adopting strategic partnerships approach to develop innovative congenital heart defect devices. Strategic partnerships support companies in the congenital heart defect devices sector by pooling resources and expertise, boosting research and development efforts, broadening market access, and speeding up commercialization. This collaboration ultimately fosters innovation and drives growth within the industry. For instance, in May 2024, SMT (Sahajanand Medical Technologies Pvt Ltd), an India-based manufacturing company, partnered with HeartX, an India-based MedTech firm to enhance patient care within the cardiovascular sector. With this partnership, Sahajanand Medical Technologies (SMT) strengthens its position in the congenital heart defect (CHD) space by integrating HeartX's innovative solutions, such as the JOVE VB Stent. This strategic alliance enables SMT to offer advanced CHD devices that enhance treatment efficacy, simplify procedures, and improve patient outcomes.
Who Are The Key Companies Actively Operating Within The Congenital Heart Defect Devices Market?
Major companies operating in the congenital heart defect devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, W L Gore & Associates Inc, Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Berlin Heart GmbH, Syncardia Systems LLC, Occlutech Holding AG, Sahajanand Medical Technologies Pvt Ltd, Xeltis AG, Procyrion Inc, Heartstitch Inc, Cardia Inc, OSYPKA Medical GmbH, On-X Life Technologies Inc, Ventracor Limited, HemoFlow Technologies, NuPulseCV Inc
Get Your In-Depth Congenital Heart Defect Devices Market Report Now:
Which Regions Are Generating The Highest Demand Within The Congenital Heart Defect Devices Market?
North America was the largest region in the congenital heart defect devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congenital heart defect devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment